Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Mechanism of Action Comparison IGF-1 LR3 Reduced IGFBP-1, -2, -3 binding affinity Extended circulating half-life (~20-30 hours) Sustained IGF-1 receptor activation Full receptor binding affinity maintained IGF-1 DES Reduced IGFBP binding via truncation Short half-life (~20-30 minutes) Rapid, acute receptor activation Enhanced receptor binding potency reported Research Applications Comparison The choice between IGF-1 LR3 and IGF-1 DES depends on the specific temporal requirements of your research
Green tea extract: Meta-analyses suggest EGCG supports small increases in energy expenditure (about 67 kcal/day) and modest weight reduction of 1.31kg over 12 weeks
Glucagon-like-peptide-1 is available in various brain zones that form an intricate complex with the regulation of appetite
Therefore, it will likely get full approval in 6 months (by summer of 2023) for weight loss in overweight/obese non-diabetic patients as we already have solid evidence of tackling the problem with GLP-1 receptor agonists
Implications for Long-Term Obesity Management This study demonstrates that structured moderate-to-vigorous exercise is the primary driver of improvements in physical fitness during long-term weight maintenance, even when weight loss is supported by GLP-1 RA therapy
US$ 29.26
US$ 21.80
US$ 23.99
US$ 23.20
